Catalyst Funds Management Pty LTD Chimerix Inc Transaction History
Catalyst Funds Management Pty LTD
- $382 Billion
- Q1 2025
A detailed history of Catalyst Funds Management Pty LTD transactions in Chimerix Inc stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 19,436 shares of CMRX stock, worth $165,983. This represents 0.04% of its overall portfolio holdings.
Number of Shares
19,436Holding current value
$165,983% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding CMRX
# of Institutions
16Shares Held
7.43MCall Options Held
0Put Options Held
0-
Magnetar Financial LLC Evanston, IL3.92MShares$33.5 Million1.23% of portfolio
-
Jpmorgan Chase & CO New York, NY1.52MShares$13 Million0.0% of portfolio
-
Black Rock Inc. New York, NY907KShares$7.74 Million0.0% of portfolio
-
Cibra Capital LTD London, X0732KShares$6.25 Million2.13% of portfolio
-
Credit Suisse Ag Zurich, V894KShares$802,7590.0% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $748M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...